News Announcement

Bafna Pharmaceuticals: Announcement under Regulation 30 (LODR)-Change in Directorate

We hereby inform that the Shareholders in the 29th Annual General Meeting held on September 25 2024 inter-alia approved the re-appointment of Ms. Shanmugam Hemalatha (DIN: 02714329) as Whole-Time Director of the Company for a period of 5 years.


दूसरी कैटेगरी